Skip to content

    Chambal Fert.

    CHAMBLFERT
    Chemicals·11 Feb 2026
    Management Summary

    Chambal Fertilisers reported a strong Q3 FY26, with standalone revenue growing 20% YoY to INR 5,898 crores, driven by robust performance in complex fertilizers and value-added segments. The company continued its momentum in crop protection chemicals and biologicals, with significant growth in volumes and revenues. The Technical Ammonium Nitrate (TAN) project is 92% complete and on track for April 2026 commissioning, while the company is also exploring vertical and horizontal expansions.

    Highlights

    5
    • Standalone revenue from operations for Q3 FY26 grew 20% YoY to INR 5,898 crores.

    • Standalone revenue for 9M FY26 increased 27% YoY to INR 18,009 crores.

    • Crop protection chemicals & specialty nutrients business, alongside biologicals, showed strong momentum with 9-month contribution growing 30% YoY.

    • Biologicals portfolio volumes increased 31% and revenues grew 58% YoY over the nine-month period.

    • Complex fertilizer segment revenues increased significantly by 81% YoY in Q3 to INR 1,850 crores, with sales volume rising to 2.94 lakh metric tons.

    Concerns

    3
    • EBITDA for Q3 FY26 took a hit of INR 31 crores on account of labor codes.

    • Complex fertilizer segment EBIT margins moderated to 4.4% in 9M FY26 from 6.87% last year.

    • A minor unscheduled stoppage due to a stripper leak for three days occurred in Gadepan-I plant during Q3.

    What Changed2

    vs Q4 FY26

    Guidance items9 → 7 (-2)Risks discussed5 → 4 (-1)
    Key financials

    Metrics

    12

    Periods

    3

    Headline

    2
    • Total Receivables (Dec 31, 2025)
      ₹2,346 Cr
    • Subsidy Receivables (Dec 31, 2025)
      ₹1,979 Cr

    Q3

    5
    • Revenue from Operations
      ₹5,898 Cr
      YoY+20%
    • EBITDA
      ₹821 Cr
      YoY+6%
    • EBITDA Margin
      13.9%
    • PAT
      ₹565 Cr
      YoY+12%
    • PAT Margin
      9.6%

    9M

    5
    • Revenue from Operations
      ₹18,009 Cr
      YoY+27%
    • EBITDA
      ₹2,424 Cr
      YoY+4%
    • EBITDA Margin
      13.5%
    • PAT
      ₹1,804 Cr
      YoY+16%
    • PAT Margin
      10.0%

    Segment breakdown

    • Urea (Q3 FY26)₹3,708 Cr15.5%
    • Complex Fertilizer (Q3 FY26)₹1,850 Cr7.7%
    • CPC, Specialty Nutrients & Seed (Q3 FY26)₹340 Cr1.4%
    • Urea (9M FY26)₹10,134 Cr42.4%
    • Complex Fertilizer (9M FY26)₹6,702 Cr28.0%
    • CPC, Specialty Nutrients & Seed (9M FY26)₹1,172 Cr4.9%
    Donut· Share of Revenue

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    ₹1,184 crores

    Liquidity

    Cash ₹800 crores

    Net cash and liquid investment as of today (Feb 11, 2026).

    Guidance & targets

    7
    CategoryTargetPriority
    Capacity
    TAN Plant Commissioning
    April 30, 2026
    High
    Capacity
    IMACID P2O5 Production Capacity
    7 lakh metric tons
    High
    Capacity
    Sulfuric Acid Capacity Increase
    Expected
    Medium
    Product Launch
    New CPC products
    12
    High
    Product Launch
    New Specialty Nutrient Product
    1
    High
    Product Launch
    TERI Partnership Products
    Expected launch
    Medium
    Shareholder Returns
    Increased Cash Returns
    No
    High

    TAN Plant Commercial Operations

    April 2026
    CurrentEPC 92% complete, pre-commissioning activities started
    TargetCommercial operations begin

    Why it matters

    Successful commissioning of the TAN plant is a major growth driver and will diversify revenue streams.

    The date of completion is scheduled for April 30, 2026.

    How to verify

    guidance_and_targets[category='Capacity'][metric='TAN Plant Commissioning']

    Risks & concerns

    4
    RiskSeverity

    Impact of Labor Codes

    EBITDA for Q3 FY26 was negatively impacted by INR 31 crores due to labor codes.Management acknowledged

    low

    DAP Margin Pressure

    High procurement prices for DAP (up to $850) and fixed margin structure (4% of MRP) dragged down overall traded business margins.Management acknowledged

    medium

    NPK/DAP Price Dynamics and Substitution Effect

    Increased input prices for phos acid and sulfuric acid, coupled with steady DAP pricing, could impact NPK off-take if the price gap becomes too wide, leading to a substitution effect.Analyst acknowledged

    medium

    G3 Policy Uncertainty

    Uncertainty regarding the government's approach to G3 policy benefits post-expiry, particularly for the Gadepan-III plant, as the government has not yet started the exercise.Analyst not addressed

    medium

    Q&A highlights

    8

    “We are just at the cusp. In fact, we had started the steam blowing and other pre-commissioning activities. So, that part is for the WNA plant and for the ANS and Melt, we should be doing that shortly thereafter. ... April.”

    Clarified the expected timeline for the TAN project's commercial production.

    asked by Prashant Biyani

    3 min read7 chapters

    Detailed Narrative

    01

    Strong Performance in Value-Added Segments

    Chambal Fertilisers demonstrated robust growth in its crop protection chemicals, specialty nutrients, and biologicals segments. The 9-month contribution from these segments grew 30% year-on-year, with the biologicals portfolio alone seeing a 58% revenue increase and 31% volume growth over the same period. The company also introduced five new products in Q3 and has a pipeline of 12 new CPC products and one specialty nutrient product slated for launch in FY27, further strengthening its differentiated portfolio.

    02

    TAN Project Nearing Completion and Expansion Plans

    The Technical Ammonium Nitrate (TAN) project is progressing well, with EPC work 92% complete as of Q3 FY26. The total estimated cost is INR 1,645 crores, with INR 1,184 crores already incurred, and management expects the project to be completed by April 30, 2026. Chambal views TAN as a critical focus area and is actively exploring both vertical and horizontal expansions, anticipating healthy capacity utilization of 75-80% post-commissioning.

    03

    Complex Fertilizer Segment Drives Revenue Growth

    The complex fertilizer segment recorded significant revenue growth, increasing 81% year-on-year to INR 1,850 crores in Q3 FY26, with sales volumes rising to 2.94 lakh metric tons from 2.13 lakh metric tons last year. For the nine-month period, revenues surged 180% to INR 6,702 crores, with sales volume reaching 11.7 lakh metric tons. However, EBIT margins for this segment moderated to 4.4% in 9M FY26 from 6.87% last year, primarily due to higher procurement costs for DAP.

    04

    Urea Segment Stability and Operational Efficiency

    The urea segment maintained stable performance, with revenues of INR 3,708 crores in Q3 and INR 10,134 crores in 9M FY26. Sales volumes were largely flat at 9.83 lakh metric tons in Q3 and 27.3 lakh metric tons in 9M. The company reported improved energy efficiency, with Gadepan-I and G-II plants operating 5-6% lower than norms and Gadepan-III 2-3% lower. A minor 3-day stripper leak in Gadepan-I was the only unscheduled stoppage in Q3, with a 30-35 day maintenance shutdown planned for Gadepan-II in Q4 FY26.

    05

    Strategic Partnerships and Digital Outreach

    Chambal Fertilisers has partnered with TERI for research in advanced and sustainable agricultural solutions, with products expected from FY27-28 and global commercial rights. The company is also exploring in-licensing opportunities with multinational companies like Nutrien Worldwide, Nichino, Syngenta, and Corteva for new products. Digital engagement efforts are strong, with the Chambal Uttam Krishak Mitra app exceeding 100,000 downloads, reflecting enhanced farmer connect and market reach.

    06

    Subsidy and Receivables Management

    The company received INR 3,880 crores in subsidy in Q3 and INR 10,228 crores in 9M FY26. Total receivables as of December 31, 2025, stood at INR 2,346 crores, including INR 1,979 crores in subsidy receivables. Management noted that INR 1,000 crores of these dues were received in January and February 2026, indicating ongoing recovery and comfort regarding the subsidy situation, supported by supplementary grants from the government.

    07

    Capital Allocation Focus on Growth and Liquidity

    The company's capital allocation is primarily directed towards growth projects like the TAN plant and capacity expansions in its IMACID joint venture (P2O5 capacity from 5 lakh MT to 7 lakh MT by Dec 2026, and sulfuric acid capacity in FY27). Management indicated no plans for increased cash returns to shareholders in the next 1-2 years, prioritizing reinvestment for growth. The company maintains a healthy net cash and liquid investment position of INR 800 crores as of the call date.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.